Sofinnova Investments, Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$3,406,000
-49.2%
65,474
-73.9%
0.20%
-59.2%
Q3 2020$6,700,000
-50.6%
250,401
-64.0%
0.50%
-41.9%
Q2 2020$13,566,000
+400.8%
696,390
+153.0%
0.86%
+240.6%
Q1 2020$2,709,000
-69.9%
275,305
-66.1%
0.25%
-61.3%
Q4 2019$9,006,000
-7.5%
811,292
-53.2%
0.65%
-26.2%
Q3 2019$9,734,000
-10.8%
1,733,628
+37.4%
0.88%
-12.3%
Q2 2019$10,911,000
+285.7%
1,261,384
+258.5%
1.00%
+267.4%
Q1 2019$2,829,000351,8110.27%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders